Study Title and Description
Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3-year results from the randomized ZEUS study.
Key Questions Addressed
|3||In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?|
Primary Publication Information
|Title||Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3-year results from the randomized ZEUS study.|
|Author||Budde K., Lehner F., Sommerer C., Arns W., Reinke P., Eisenberger U., Wüthrich RP., Scheidl S., May C., Paulus EM., Mühlfeld A., Wolters HH., Pressmar K., Stahl R., Witzke O.|
|Country||Department of Nephrology, Charité Universitätsmedizin Berlin, Berlin, Germany. email@example.com|
Pubmed ID: 22642473
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Comparative Effectiveness of Regimens
Results & Comparisons
No Results found.